Oncogenic KRAS desensitizes colorectal tumor cells to epidermal growth factor receptor inhibition and activation.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 2887497)

Published in Neoplasia on June 01, 2010

Authors

Winan J van Houdt1, Frederik J H Hoogwater, Menno T de Bruijn, Benjamin L Emmink, Maarten W Nijkamp, Danielle A E Raats, Petra van der Groep, Paul van Diest, Inne H M Borel Rinkes, Onno Kranenburg

Author Affiliations

1: Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, The Netherlands.

Articles citing this

Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics (2014) 1.22

Identification of mutant K-Ras-dependent phenotypes using a panel of isogenic cell lines. J Biol Chem (2012) 0.90

Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression. Neoplasia (2012) 0.90

Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration. Neoplasia (2012) 0.89

Protein expression signatures for inhibition of epidermal growth factor receptor-mediated signaling. Mol Cell Proteomics (2011) 0.86

PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response. J Clin Invest (2015) 0.86

Synergistic induction of apoptosis by salinomycin and gefitinib through lysosomal and mitochondrial dependent pathway overcomes gefitinib resistance in colorectal cancer. Oncotarget (2017) 0.84

Immunological visibility: posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathway. Sci Transl Med (2014) 0.82

Personalizing colon cancer therapeutics: targeting old and new mechanisms of action. Pharmaceuticals (Basel) (2013) 0.81

Evaluation of antibody-dependent cell-mediated cytotoxicity activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients. World J Gastrointest Oncol (2016) 0.77

The interconnectedness of cancer cell signaling. Neoplasia (2011) 0.75

Dinosaurs and ancient civilizations: reflections on the treatment of cancer. Neoplasia (2010) 0.75

The K-Ras effector p38p38γMAPK confers intrinsic resistance to tyrosine kinase inhibitors by stimulating EGFR transcription and EGFR de-phosphorylation. J Biol Chem (2017) 0.75

Articles cited by this

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med (2004) 30.26

K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med (2008) 27.35

Lessons from hereditary colorectal cancer. Cell (1996) 25.73

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med (2009) 22.23

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol (2008) 20.89

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol (2008) 11.73

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol (2008) 9.98

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol (2004) 9.73

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J Clin Oncol (2007) 9.29

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol (2009) 8.66

EGFR and cancer prognosis. Eur J Cancer (2001) 7.52

Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res (2003) 6.43

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab. Ann Oncol (2007) 5.68

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. Lancet Oncol (2008) 4.86

Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science (1993) 4.76

Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer (2008) 4.25

Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res (2009) 3.70

Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab. J Clin Oncol (2009) 2.92

Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis. Proc Natl Acad Sci U S A (2002) 2.65

Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res (1995) 1.71

Peptide growth factors in the intestine. Eur J Gastroenterol Hepatol (2001) 1.67

Primary cultures of fully differentiated and pure human intestinal epithelial cells. Exp Cell Res (1998) 1.54

Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice. J Biol Chem (2004) 1.35

Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells. Cancer Res (2009) 1.13

Differential Notch and TGFbeta signaling in primary colorectal tumors and their corresponding metastases. Cell Oncol (2008) 1.06

Epidermal growth factor receptor-targeted therapy in colorectal cancer. Semin Oncol (2002) 1.04

Regulating c-Ras function. cholesterol depletion affects caveolin association, GTP loading, and signaling. Curr Biol (2001) 0.99

Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. Br J Cancer (1999) 0.99

Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy. Oncogene (2005) 0.95

Phase I combination of sorafenib and erlotinib therapy in solid tumors: safety, pharmacokinetic, and pharmacodynamic evaluation from an expansion cohort. Mol Cancer Ther (2010) 0.94

Articles by these authors

Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med (2013) 4.74

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer (2003) 3.47

Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology (2007) 2.43

Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun (2007) 2.06

Intravital microscopy through an abdominal imaging window reveals a pre-micrometastasis stage during liver metastasis. Sci Transl Med (2012) 2.02

Receptor conversion in distant breast cancer metastases. Breast Cancer Res (2010) 1.85

Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. J Biol Chem (2009) 1.83

Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg (2012) 1.78

Additional value of contrast enhanced intraoperative ultrasound for colorectal liver metastases. Eur J Radiol (2007) 1.60

Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res (2003) 1.51

The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol (2003) 1.48

Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy. Ann Surg (2011) 1.44

Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions? Breast Cancer Res Treat (2004) 1.44

Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers. Endocr Relat Cancer (2012) 1.40

Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer (2008) 1.39

Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology (2005) 1.37

Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon. Ann Surg (2009) 1.24

Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression. EMBO J (2009) 1.22

Control of colorectal metastasis formation by K-Ras. Biochim Biophys Acta (2005) 1.22

Liver regeneration is an angiogenesis- associated phenomenon. Ann Surg (2002) 1.21

Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1alpha (HIF-1alpha). Oncogene (2003) 1.20

Surgical implantation of an abdominal imaging window for intravital microscopy. Nat Protoc (2013) 1.19

Molecular subtyping of male breast cancer by immunohistochemistry. Mod Pathol (2011) 1.17

Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells. Gastroenterology (2010) 1.16

Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. Gastroenterology (2011) 1.15

Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance. J Clin Invest (2011) 1.13

Glycation induces formation of amyloid cross-beta structure in albumin. J Biol Chem (2003) 1.12

Hemorrhoidal artery ligation procedure with or without Doppler transducer in grade II and III hemorrhoidal disease: a blinded randomized clinical trial. Ann Surg (2012) 1.12

Feasibility of robot-assisted laparoscopic surgery: an evaluation of 35 robot-assisted laparoscopic cholecystectomies. Surg Laparosc Endosc Percutan Tech (2002) 1.12

PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells. Neoplasia (2013) 1.11

CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation. J Hepatol (2010) 1.10

Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth. J Surg Oncol (2010) 1.08

Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur J Cancer (2008) 1.07

Robot-assisted endoscopic surgery: a four-year single-center experience. Dig Surg (2005) 1.06

Differential Notch and TGFbeta signaling in primary colorectal tumors and their corresponding metastases. Cell Oncol (2008) 1.06

Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod Pathol (2012) 1.06

Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res (2004) 1.06

Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: a prospective case series of 960 patients. Cancer (2013) 1.05

HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages. Atherosclerosis (2007) 1.04

Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. Int J Pharm (2006) 1.04

Chromosomal changes in relation to clinical outcome in larynx and pharynx squamous cell carcinoma. Cell Oncol (2005) 1.01

Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model. BJU Int (2012) 1.00

Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis. Cell Oncol (2007) 1.00

The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors. Cancer Res (2008) 1.00

Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer. PLoS One (2012) 0.98

Validation of bioluminescence imaging of colorectal liver metastases in the mouse. J Surg Res (2004) 0.98

Perinecrotic hypoxia contributes to ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. Am J Pathol (2007) 0.98

Mouse models in liver cancer research: a review of current literature. World J Gastroenterol (2008) 0.98

International survey on esophageal cancer: part I surgical techniques. Dis Esophagus (2009) 0.97

Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma. BMC Cancer (2010) 0.97

Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study. Ann Surg Oncol (2010) 0.96

Expression and localization of hypoxia proteins in prostate cancer: prognostic implications after radical prostatectomy. Urology (2009) 0.95

Active HIF-1 in the normal human retina. J Histochem Cytochem (2009) 0.95

Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy. Oncogene (2005) 0.95

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst (2004) 0.94

Robot-assisted pancreatic surgery: a systematic review of the literature. HPB (Oxford) (2012) 0.94

Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy. World J Surg Oncol (2006) 0.94

Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer. PLoS One (2013) 0.93

Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling. Cancer Res (2013) 0.93

KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res (2006) 0.92

Surgery and angiogenesis. Biochim Biophys Acta (2004) 0.92

Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res (2002) 0.92

Immunophenotyping invasive breast cancer: paving the road for molecular imaging. BMC Cancer (2012) 0.92

Novel molecular pathways in Gorham disease: implications for treatment. Pediatr Blood Cancer (2013) 0.91

Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patients. Eur J Endocrinol (2011) 0.91

Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Endocr Pract (2011) 0.91

Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study. World J Surg (2010) 0.90

Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer. Cell Oncol (Dordr) (2011) 0.90

Ageing and hepatic steatosis exacerbate ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. Ann Surg Oncol (2008) 0.90

Minimally invasive ablative therapies for invasive breast carcinomas: an overview of current literature. World J Surg (2007) 0.90

The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma. Urology (2009) 0.89

Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression. Lab Invest (2006) 0.89